Dr. Geoffrey Coxon University of Strathclyde, UK

Geoff Coxon carried out his PhD research under the supervision of Prof. David Minnikin at the University of Newcastle upon Tyne in 1999. After working initially at the Department of Pure & Applied Chemistry at Newcastle, working with Prof. David Sherrington, Dr. Coxon moved to the Strathclyde Institute of Pharmacy... read moreand Biomedical Sciences. In this role he designed and optimized compounds for the treatment of obesity, both in vitro and in vivo, which are now subject to licensing discussions with industry to further develop these towards the clinic. In December 2004 Dr. Coxon was appointed lecturer in Medicinal Chemistry SIPBS where he began establishing his research group focused on anti-TB drug discovery. During 2007 Dr. Coxon and colleagues embarked on the establishment of a UK consortium to bring together scientists involved in TB drug discovery. A year later, TBD-UK was established and subsequent funding obtained from the MRC to develop the program and consolidate UK research. As part of TBD-UK, Dr. Coxon has taken ownership and development of www.TBD-UK.org.uk and as deputy leader and director of medicinal chemistry is committed to the discovery of new TB drugs.